𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinct roles of different fragments of PDCD4 in regulating the metastatic behavior of B16 melanoma cells

✍ Scribed by Guo, Shu

Book ID
120303393
Publisher
Spandidos Publications Ltd
Year
2013
Tongue
English
Weight
797 KB
Volume
42
Category
Article
ISSN
1019-6439

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The regulation of cyclic AMP production
The regulation of cyclic AMP production and the role of cyclic AMP in B16 melanoma cells of differing metastatic potential
✍ S. E. Hill; R. C. Rees; S. MacNeil πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 1000 KB

The nature of the relationship between agonist-stimulated cyclic AMP production and metastatic potential was examined in detail for four B16 melanoma cell lines of varying metastatic potential. Highly metastatic cells (B16 F10C1) appeared to differ from cells of low metastatic potential (B16 F1C29)

Distinct regulation of pHin and [Ca2+]in
Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential
✍ Raul MartΓ­nez-ZaguilΓ‘n; Gloria M. Martinez; Araceli Gomez; Mary J. C. Hendrix; R πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 222 KB

We investigated whether alterations in the mechanisms involved in intracellular pH (pH in ) and intracellular calcium ([Ca 2/ ] in ) homeostasis are associated with the metastatic potential of poorly (A375P) and highly (C8161) metastatic human melanoma cells. We monitored pH in and [Ca 2/ ] in simul

Unequal forms of 140–110 kD glycoprotein
Unequal forms of 140–110 kD glycoproteins in B16 melanoma cells with differing detachment properties and metastatic behavior: Influence of bromodeoxyuridine
✍ Manuel Rieber; Miguel A. Castillo πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 755 KB

## Abstract Growth of B16 melanoma metastatic variants with 2.5 ΞΌg/ml of bromodeoxyuridine (BrdU) decreases cell detachment from the substratum, as measured by resistance to release by trypsin‐EDTA treatment. Using an antiserum to intact melanoma cells and metabolic labelling of melanoma metastatic